Compound ID | 2655
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Escherichia coli, Salmonella typhosa, Staphylococcus aureus, Streptococcus pyogenes, and Mycobacterium sp. |
| Description: | Natural product from Arthrobacter oxamicetus; structurally resembles amicetin; protects mice from Staphylococcus aureus when administered subcutaneously but not when given orally |
| Institute where first reported: | Bristol-Banyu Research Institute, Ltd., Meguro, Tokyo, Japan |
| Year first mentioned: | 1973 |
| Development status: | Experimental |